Health Care & Life Sciences » Biotechnology | Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
22.67 M
Public Float
18.26 M
Aptevo Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.19
Market Cap
$39.68 M
Shares Outstanding
45.09 M
Public Float
18 M

Profile

Address
2401 4th Avenue
Seattle Washington 98121
United States
Employees -
Website http://aptevotherapeutics.com
Updated 07/08/2019
Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics. Its pipeline includes Otlertuzumab, APVO414, APVO436, ROR1 Candidate, and ALG. APV-527.

Financials

View All

Fuad El Hibri
Chairman
Marvin L. White
President, Chief Executive Officer & Director